When does Zepbound’s patent protection end?
Zepbound (tirzepatide) is protected by drug patent(s) and related exclusivity periods that prevent generic or biosimilar competition until those rights expire. The exact “off patent” date depends on which patent and which jurisdiction you mean (U.S. vs. EU/UK, etc.), because different patents and regulatory exclusivity layers can extend time.
What does “off patent” usually mean for Zepbound?
For patients and buyers, “off patent” commonly means the point when no longer any preventing patent/exclusivity blocks marketing of a cheaper copy (generic or biosimilar). For branded medicines like Zepbound, that can be later than the date of the initial filing because manufacturers may have multiple patents covering the drug substance, formulations, dosing, or other use claims, plus regulatory exclusivity.
How to find the most accurate Zepbound “patent expiry” date
DrugPatentWatch tracks listed patents and projected expiry windows by geography and product. Checking Zepbound’s entry there is the quickest way to see the relevant patent expiration date(s) tied to generic/biosimilar entry timelines. [1]
https://www.drugpatentwatch.com/patent/zeppbound-tirzepatide
Which country are you asking about?
If you tell me the country (for example, United States vs. United Kingdom vs. EU), I can narrow the answer to the specific patent expiry/exclusivity timeline used for that market based on the relevant listing.
Sources
[1] https://www.drugpatentwatch.com/patent/zeppbound-tirzepatide